Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 26, 2024; 12(18): 3378-3384
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3378
Comparative effects of insulin pump and injection on gestational diabetes mellitus pregnancy outcomes and serum biomarkers
Yan Wang, Wan Gao, Xiao-Juan Wang
Yan Wang, Wan Gao, Xiao-Juan Wang, Department of Obstetrics and Gynaecology, Xi'an Central Hospital, Xi'an 710003, Shaanxi Province, China
Author contributions: Wang XJ designed the study, Gao W performed the data collection and analysed the data, and Wang Y wrote the manuscript; All authors reviewed the manuscript.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of Xi'an Central Hospital Medical, No. LW-2024-011.
Informed consent statement: The data used in the study were not involved in the patients’ privacy information, and all patient data obtained, recorded, and managed only used for this study, without any harm to the patient. So, the informed consent was waived by the Ethics Committee of Xi'an Central Hospital.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Data were obtained by contacting the corresponding author at 13991924715@163.com.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Juan Wang, BMed, Associate Chief Physician, Department of Obstetrics and Gynaecology, Xi'an Central Hospital, No. 161 Xiwu Road, Xincheng District, Xi'an 710003, Shaanxi Province, China. 13991924715@163.com
Received: March 4, 2024
Revised: April 24, 2024
Accepted: May 14, 2024
Published online: June 26, 2024
Processing time: 106 Days and 1.4 Hours
Core Tip

Core Tip: This study delineates the comparative efficacy of continuous subcutaneous insulin infusion (CSII) via insulin pumps and multiple daily injections in managing gestational diabetes mellitus (GDM), focusing on pregnancy outcomes and serum biomarkers. It reveals CSII's superior capability in enhancing glycemic control, reducing pain, and decreasing the incidence of fetal distress and premature rupture of membranes, without significantly altering other pregnancy outcomes. Highlighting the novel insight into CSII's role in modulating key metabolic biomarkers, this research contributes to optimizing GDM management strategies, offering a significant leap towards personalized diabetic care in pregnancy.